Navigation Links
First Controlled Large-Scale Intervention Angiotensin Receptor,Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study,Demonstrates Significant Reduction in Blood Pressure and Protection,of Organs with Valsartan

ypertension, ischemic heart disease or congestive heart failure. The primary endpoint was the onset of new or recurrent stroke, new or transient ischemic attack, hospitalization for congestive heart failure or angina pectoris, heart attack, aortic dissection, lower limb arterial obstruction, doubling of serum creatinine, or transition to dialysis. At the start of the clinical study, as well as during the course of the study, blood pressure and heart rate did not differ between the valsartan regime and the control regime.

The chief investigator was Seibu Mochizuki, M.D., PhD, Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, and the joint chief investigator was Bjorn Dahlof, Associate Professor, Department of Medicine, University of Goteborg Sahlgrenska University Hospital, Sweden.

The Jikei University School of Medicine

The Jikei University School of Medicine has its origins in the Sei-I-Kwai Koshujo (Medical Training School), the precursor to the University, which was founded in 1881 by Kenehiro Takaki. It is the oldest medical school in Japan. The Jikei University School of Medicine is currently positioned as one of the four educational institutions operated by the University, consisting of the Faculty of Medicine, the Medical Research department of the graduate school, four University hospitals, a clinic and the Research Center for Medical Sciences. At the four University hospitals there are approximately 2,600 beds and approximately 7,500 outpatients visit daily, making them the largest university hospitals in Japan.

In education, research and medical care, the Jikei University School of Medicine always adopts the founding spirit of Kanehiro Takaki of treating patients as human beings suffering from an illness, rather than examining them as research material. The University also devotes itself to the promotion of clinical research, of which Takaki is said to be the originator.

    
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
(Date:4/24/2015)... 2015 Research and Markets ... of the "Lab Accessories Market by ... Station) & End User (OEM/Biotechnology & Pharmaceutical ... 2020" report to their offering. ... expected to reach $504.7 million by 2020 ...
(Date:4/24/2015)... , April 24, 2015  Lannett Company, Inc. ... amended and increased its five-year revolving credit facility to ... an accordion feature that will allow the company to ... additional $30.0 million, subject to securing additional commitments from ... of the credit facility remains December 18, 2018.   ...
(Date:4/23/2015)... NORTH CHICAGO, Ill. , April 24, 2015 /PRNewswire/ ... U.S. Food and Drug Administration (FDA) has accepted its ... the company,s, all-oral, interferon-free, two direct-acting antiviral treatment of ... is for the treatment of adults with chronic genotype ... AbbVie,s regimen is the first all-oral, interferon-free therapy being ...
Breaking Medicine Technology:Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 2Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 3Lannett Expands Revolving Credit Facility To $120 Million 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7
(Date:4/25/2015)... York (PRWEB) April 25, 2015 ... for vaginal mesh lawsuits filed against C.R. Bard, ... District Court, Southern District of West Virginia. According ... Scheduling Conference was convened that day, after certain ... Long Form Complaint. The Order directed that any ...
(Date:4/25/2015)... Henderson, NV (PRWEB) April 25, 2015 ... Program is still eliciting the excitement of the public ... well into the months of May and June. ... Wellness™ held their biannual tradition of "Special Prayers." More ... who had attended previous Special Prayers and have reported ...
(Date:4/25/2015)... (PRWEB) April 25, 2015 Parker and Sons ... and cooling, has spiked in Arizona alongside the growing economy. ... additional forty employees for April to help account for the ... forty employees in April is something we are enthusiastic about. ... said Paul Kelly, president at Parker and Sons. , Indeed, ...
(Date:4/25/2015)... Dallas, TX/Minneapolis, MN (PRWEB) April 25, 2015 ... as the recipient of RFID Journal’s annual Best Implementation ... company that has demonstrated the best use of RFID ... operations. The winner is the company that best demonstrates ... The award was presented at RFID Journal Live! 2015 ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 Constellations Recovery ... residence in Westchester County. Just 35 miles from New ... individuals back into everyday life while recovering from addiction. ... 7, 2015, will allow therapists, doctors and treatment centers ... learn more about the opportunities offered by Constellations Recovery., ...
Breaking Medicine News(10 mins):Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 3Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 4Health News:Trivedi Master Wellness™ Announces the Resounding Success of their Special Prayers Human Wellness Program 2Health News:Trivedi Master Wellness™ Announces the Resounding Success of their Special Prayers Human Wellness Program 3Health News:Parker and Sons Plans to Expand in 2015 2Health News:Seeonic’s Industry Leading Technology Powers Interstate Batteries to Winning Award 2Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 2Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 3
... C did little to protect healthy men, either , , ... released Sunday cast doubt on the cardiac benefits of ... researchers found that low-dose aspirin did not reduce the ... diabetes. , Second, Harvard researchers concluded that neither vitamin ...
... Nov. 9, 2007 Mark Twain, a skeptic of the ... Man?" that humans do not command their minds or the ... a speaker identified as "old man" says in the essay. ... reflection or the need of it." , Twain,s views get ...
... interference when placed too closely to pacemakers, ICDs , , ... for your iPod into your coat pocket might not ... normal functioning of your implanted cardiac device. ... Association,s annual scientific sessions, in New Orleans, report that ...
... 9 The NHS Human,Services Foundation held its fifth ... the Hyatt Regency Penn,s Landing in Philadelphia. This event ... supports the mission,of NHS Human Services, one of the ... Every year the Foundation presents the Leading the ...
... Academy of Ophthalmology (Academy) and European Society of Ophthalmology ... meeting in the world, is in session November ... Center, Atlanta. Offerings include 277 continuing medical education ... transfer courses, and more than 100 hours of scientific ...
... Cataract Surgery Patients can Better Understand Their Condition at CataractSurgery.com ... ... Cataract surgery patients and their caregivers now have a new online ... . Cataracts affect nearly 20 million Americans age 60 ...
Cached Medicine News:Health News:Aspirin Doesn't Guard Diabetics Against Heart Disease 2Health News:Aspirin Doesn't Guard Diabetics Against Heart Disease 3Health News:Aspirin Doesn't Guard Diabetics Against Heart Disease 4Health News:Simple brain mechanisms explain arbitrary human visual decisions 2Health News:Simple brain mechanisms explain arbitrary human visual decisions 3Health News:MP3 Player Headphones May Throw Off Cardiac Devices 2Health News:MP3 Player Headphones May Throw Off Cardiac Devices 3Health News:Gala Raises Funds for NHS Human Services 2Health News:AAO-SOE Joint Meeting research highlights 2Health News:AAO-SOE Joint Meeting research highlights 3Health News:AAO-SOE Joint Meeting research highlights 4Health News:Alcon Sponsors Online Educational Initiative for Patients Considering Cataract Surgery 2
... patch, Duragen is a matrix for ... handles and conforms similar to normal ... matrix for dural closure. Remarkable onlay ... defects. Fully resorbed following complete tissue ...
The Bovie IDS Series are the latest electrosurgical generators with fully digital implementation....
Elmed electrosurgical systems for major surgery....
Aaron 1250 is a multipurpose electrosurgical generator with monopolar and bi-polar functions....
Medicine Products: